Menlo Therapeutics Inc.Company Review & Valuation

MNLO
Nasdaq
Latest Price
1.63USD
Market Capitalization
39.78mUSD

About Menlo Therapeutics Inc.

Menlo Therapeutics Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of serlopitant for the treatment of pruritus associated with dermatologic conditions in the United States. The company has completed Phase II clinical trials in pruritus associated with Show moreprurigo nodularis. It is also developing products that are in Phase II clinical trials to treat pruritus associated with psoriasis, atopic dermatitis, and refractory chronic cough. The company was formerly known as Tigercat Pharma, Inc. and changed its name to Menlo Therapeutics Inc. in May 2016. Menlo Therapeutics Inc. was founded in 2011 and is headquartered in Redwood City, California.Show less

Industry
Biotechnology
HQ Location
Redwood City, California

Stock Price

Price data not available for Menlo Therapeutics Inc..

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

United Therapeutics
Gilead Sciences
KalVista Pharmaceuticals
Atara Biotherapeutics

back to top